159 related articles for article (PubMed ID: 38606896)
1. Systematic review on efficacy and safety of empirical versus pre-emptive antifungal therapy among children with febrile neutropenia reveals paucity of data.
Sachdeva M; Malik M; Pradhan P; Kaur K; Dogra S; Mathew JL
Mycoses; 2024 Apr; 67(4):e13722. PubMed ID: 38606896
[TBL] [Abstract][Full Text] [Related]
2. Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.
Uneno Y; Imura H; Makuuchi Y; Tochitani K; Watanabe N
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013604. PubMed ID: 36440894
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial.
Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Farfán M; de la Maza V; Vergara A; Valenzuela R; Torres JP
J Antimicrob Chemother; 2018 Oct; 73(10):2860-2866. PubMed ID: 30010931
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
[TBL] [Abstract][Full Text] [Related]
7. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
8. Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis.
Chen K; Wang Q; Pleasants RA; Ge L; Liu W; Peng K; Zhai S
BMC Infect Dis; 2017 Feb; 17(1):159. PubMed ID: 28219330
[TBL] [Abstract][Full Text] [Related]
9. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.
Pagano L; Caira M; Nosari A; Cattaneo C; Fanci R; Bonini A; Vianelli N; Garzia MG; Mancinelli M; Tosti ME; Tumbarello M; Viale P; Aversa F; Rossi G;
Haematologica; 2011 Sep; 96(9):1366-70. PubMed ID: 21565903
[TBL] [Abstract][Full Text] [Related]
10. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
Rivas-Ruiz R; Villasis-Keever M; Miranda-Novales G; Castelán-Martínez OD; Rivas-Contreras S
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009031. PubMed ID: 30887505
[TBL] [Abstract][Full Text] [Related]
11. Clinical considerations in the early treatment of invasive mould infections and disease.
Mercier T; Maertens J
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i29-i38. PubMed ID: 28355465
[TBL] [Abstract][Full Text] [Related]
12. Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis.
Goldberg E; Gafter-Gvili A; Robenshtok E; Leibovici L; Paul M
Eur J Cancer; 2008 Oct; 44(15):2192-203. PubMed ID: 18706808
[TBL] [Abstract][Full Text] [Related]
13. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
[TBL] [Abstract][Full Text] [Related]
14. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
[TBL] [Abstract][Full Text] [Related]
15. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
16. Antifungal pre-emptive strategy for high-risk neutropenic patients: why the story is still ongoing.
Cordonnier C; Robin C; Alanio A; Bretagne S
Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():27-35. PubMed ID: 24283975
[TBL] [Abstract][Full Text] [Related]
17. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.
Wagner C; Griesel M; Mikolajewska A; Metzendorf MI; Fischer AL; Stegemann M; Spagl M; Nair AA; Daniel J; Fichtner F; Skoetz N
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014963. PubMed ID: 36385229
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
[TBL] [Abstract][Full Text] [Related]
19. Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
Yamashita C; Takesue Y; Matsumoto K; Ikegame K; Enoki Y; Uchino M; Miyazaki T; Izumikawa K; Takada T; Okinaka K; Ueda T; Miyazaki Y; Mayumi T
J Infect Chemother; 2020 Jun; 26(6):596-603. PubMed ID: 32171659
[TBL] [Abstract][Full Text] [Related]
20. Is preemptive antifungal therapy a good alternative to empirical treatment in prolonged febrile neutropenia?
Koch E; Rada G
Medwave; 2016 Jun; 16 Suppl 2():e6463. PubMed ID: 27280389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
